AEBi
Therapeutic Peptides for Personalized Cancer Treatment
StartupAEBi is a Ness Ziona-based startup in the Health Tech & Life Sciences sector, established in 2000. Therapeutic Peptides for Personalized Cancer Treatment. AEBi was founded by Ilan Morad, PhD. The company has 1-10 employees. Core technologies: Biologicals, Molecules.
The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StagePre-Funding
- ProductR&D
- ModelB2B
- Employees1-10
- HQNess Ziona
- DistrictCenter District
- Last RoundUndisclosed
Ilan Morad, PhDFounder & CEO
3 articles covered by sources including www.irishtimes.com,
www.timesofisrael.com,
www.forbes.com.
What does AEBi do?
Accelerated Evolution Biotechnologies (AEBi) is a development-stage biopharmaceutical company engaged in the discovery and development of therapeutic peptides. The company has developed an IP-protected combinatorial biology screening platform technology that can be used to find binders to known targets and select the best functional molecules among them. AEBis platform is extremely flexible, harnessing combinatorial biology to discover new and better lead compounds to disease targets. AEBi was incorporated at the Weizmann Institutes ITEK technological incubator in Nes-Tziona, Israel. The company has a collaboration agreement with Israeli biopharmaceutical company Proteologics.
Who founded AEBi?
AEBi was founded in 2000 by Ilan Morad, PhD (Founder & CEO).
What sector is AEBi in?
AEBi operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is AEBi located?
AEBi is based in Einstein St 13, Ness Ziona, Israel, Center District.